Bill Maris: How Google Could Crush AI Competitors, Why Small Funds Win, and AI's Atari Stage – All-In with Chamath, Jason, Sacks & Friedberg

Bill Maris: How Google Could Crush AI Competitors, Why Small Funds Win, and AI's Atari Stage – All-In with Chamath, Jason, Sacks & Friedberg — Transcript

Market views

Bullish

CRWD— Section 32 invested in CrowdStrike, which is mentioned as one of their portfolio companies performing in the top decile across all six funds.
COIN— Section 32 invested in Coinbase, which is mentioned as one of their portfolio companies performing in the top decile across all six funds.
COHERE— Section 32 invested in Cohere, which is mentioned as one of their portfolio companies performing in the top decile across all six funds.
AIINFRA— Bill is focused on investing in the infrastructure layer of AI (physics engines, controllers, GPUs) rather than larger models, comparing the opportunity to the evolution from Atari to PlayStation 10 happening in the next 5 years.
BIOTECH— Bill sees human biology and healthcare as having the largest total addressable market and is interested in computational biology, though cautious about therapeutic trials requiring FDA approval.
NEWLIMIT— Bill is an investor in New Limit, Blake Byers and Brian Armstrong's longevity company, indicating interest in the longevity/human health space.

Bearish

OPENAI— Bill suggests OpenAI and Anthropic face existential business model risk if Google cuts token prices by 80%, which he believes would be the rational move for Google to compress competition.
ANTHROPIC— Bill suggests Anthropic faces existential business model risk if Google cuts token prices by 80%, and questions whether companies with trillion-dollar spend commitments on $60B revenue can justify valuations to public markets.
LARGEFUNDS— Bill presents data showing large VC funds (>$1B) significantly underperform smaller funds (<$750M), with top decile returns of 2.42x vs 4.76x, and argues the incentive structure is broken.
LATESTAGEVC— Bill criticizes late-stage VC as not true venture capital and questions the sustainability of multi-trillion dollar exits, arguing companies staying private longer forces overpriced IPOs onto retail investors.

Not investment advice.

Mentioned

Market views